Cash Flow from Operating Activities: A company's cash flows from operations.
Ventyx Biosciences, Inc. (VTYX) had Cash Flow from Operating Activities of $-130.87M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-135.12M |
|
-- |
|
-- |
|
$148.45M |
|
$-148.45M |
|
$13.33M |
|
$-135.12M |
|
$-135.12M |
|
$-135.12M |
|
$-135.12M |
|
$-135.12M |
|
$-135.12M |
|
$-148.45M |
|
$-147.10M |
|
68.48M |
|
68.48M |
|
$-1.97 |
|
$-1.97 |
|
| Balance Sheet Financials | |
$229.62M |
|
$0.61M |
|
$46.94M |
|
$276.56M |
|
$12.78M |
|
-- |
|
$9.74M |
|
$22.52M |
|
$254.04M |
|
$254.04M |
|
$254.04M |
|
71.13M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-130.87M |
$-15.51M |
|
$122.11M |
|
$52.55M |
|
$28.23M |
|
$-24.32M |
|
$22.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-131.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-53.19% |
|
-53.19% |
|
-48.86% |
|
-53.19% |
|
$3.57 |
|
$-1.91 |
|
$-1.91 |
|